Gene · 3914
Papers1,750
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,750
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular matrix in skin diseases: The road to new therapies. | J Adv Res | 2023 | 36481476 | PubTator, text mining | PubMed |
| Whole exome sequencing of 28 families of Danish descent reveals novel candidate genes and pathways in developmental dysplasia of the hip. | Mol Genet Genomics | 2023 | 36454308 | PubTator, text mining | PubMed |
| Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19. | Gene | 2023 | 36379381 | PubTator, text mining | PubMed |
| Phenotypic variability in LAMA3-associated amelogenesis imperfecta. | Oral Dis | 2023 | 36326426 | PubTator, text mining | PubMed |
| hsa-mir-133a-2 promotes the proliferation and invasion of cervical cancer cells by targeting the LAMB3-mediated PI3K/ATK pathway. | Cancer Med | 2023 | 36305754 | PubTator, text mining | PubMed |
| Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China. | J Eur Acad Dermatol Venereol | 2023 | 36287101 | PubTator, text mining | PubMed |
| Data-independent acquisition and quantification of extracellular matrix from human lung in chronic inflammation-associated carcinomas. | Proteomics | 2023 | 36228107 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| miR-24-3p Regulates Epithelial-Mesenchymal Transition and the Malignant Phenotype of Pancreatic Adenocarcinoma by Regulating ASF1B Expression. | Biochem Genet | 2023 | 36114946 | PubTator, text mining | PubMed |
| The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. | Front Immunol | 2022 | 36776395 | PubTator, text mining | PubMed |
| Prognostic risk analysis related to radioresistance genes in colorectal cancer. | Front Oncol | 2022 | 36741692 | PubTator, text mining | PubMed |
| Upregulation of miR-142 in papillary thyroid carcinoma tissues: a report based on in silico and in vitro analysis. | Mol Biol Res Commun | 2022 | 36718241 | PubTator, text mining | PubMed |
| Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification. | Taiwan J Ophthalmol | 2022 | 36660127 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management. | Cancers (Basel) | 2022 | 36612247 | PubTator, text mining | PubMed |
| S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis. | Cancers (Basel) | 2022 | 36612197 | PubTator, text mining | PubMed |
| The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. | Cells | 2022 | 36611918 | PubTator, text mining | PubMed |
| Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma. | Front Oncol | 2022 | 36605426 | PubTator, text mining | PubMed |
| Arterial Tortuosity Syndrome in a Newborn: A Case Report With Literature Review. | Cureus | 2022 | 36578839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3914/papers?page=14